ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE
|
|
|
- Shauna Jefferson
- 5 years ago
- Views:
Transcription
1 ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE Heart diseases and stroke are the top causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke. To reverse these trends, care teams must assess risk of cardiovascular disease for people with Type 2 diabetes and intervene in order to prevent these major health events. TIPS TO INCORPORATE CARDIOVASCULAR RISK ASSESSMENT n Use the ACC/AHA ASCVD Risk Calculator (refer to Appendix E: Suggested Readings for a link) for all patients with Type 2 diabetes over 40 years old annually, but including those who are newly diagnosed with the condition. n Develop a workflow to facilitate ease of adoption. This workflow may incorporate: Inclusion of point-of-care alerts, Care teams systematically evaluate each patient s risk for cardiovascular disease, using a trusted risk assessment tool. For patients at risk, treatment plans include primary and secondary prevention in accordance with American Diabetes Association (ADA) recommendations for lifestyle, lipid-lowering and antihypertensive medications, and aspirin. Delegation of this responsibility (e.g., to a medical assistant or care coordinator), Development of automated tools built into the EHR, and Utilization monitoring of these tools (e.g., Did a point-of-care alert appear and was statin ordered, if appropriate? Did medication reconciliation include statin adherence over 80%?). n Ensure the results are entered into the EHR and/or your diabetes registry in a discrete, searchable field. n Educate clinicians and care team members about the importance of cardiovascular risk assessment for patients with Type 2 diabetes, the approved workflow, and appropriate management per your organization s treatment algorithms (refer to Adopt Treatment Algorithm plank). n Develop or adopt treatment guidelines that include use of moderate- or high-intensity statins, lifestyle changes, antihypertensive medications, and aspirin for at-risk patients. n Establish a process to assess medication adherence such as patient questionnaires, selfreports, pill counts, and pharmacy refills. n Offer patient education materials and selfmanagement tools that are culturally appropriate and accessible to audiences with low literacy. n Monitor use of the risk calculator and adherence to the workflow and report back to the Accountable Diabetes Team at your organization (refer to Build an Accountable Diabetes Team plank). n Leverage the work previously completed in your organization with Measure Up/Pressure Down or other related efforts. ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE 73
2 TOOL: CARDIOVASCULAR DISEASE ALGORITHM INTERMOUNTAIN HEALTHCARE Used with permission from Intermountain Healthcare. Copyright , Intermountain Healthcare. CAMPAIGNTOOLKIT
3 INTERMOUNTAIN HEALTHCARE ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE TOOL: CARDIOVASCULAR DISEASE ALGORITHM (CONTINUED) 75
4 TOOL: CHOLESTEROL ALGORITHM INTERMOUNTAIN HEALTHCARE Used with permission from Intermountain Healthcare. Copyright , Intermountain Healthcare. CAMPAIGNTOOLKIT
5 INTERMOUNTAIN HEALTHCARE ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE TOOL: CHOLESTEROL ALGORITHM (CONTINUED) 77
6 TOOL: HYPERTENSION ALGORITHM INTERMOUNTAIN HEALTHCARE Used with permission from Intermountain Healthcare. Copyright , Intermountain Healthcare. CAMPAIGNTOOLKIT
7 INTERMOUNTAIN HEALTHCARE ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE TOOL: HYPERTENSION ALGORITHM (CONTINUED) 79
8 TOOL: ADULT LIPID GUIDELINES SUTTER HEALTH CAMPAIGNTOOLKIT
9 SUTTER HEALTH ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE TOOL: ADULT LIPID GUIDELINES (CONTINUED) 81
10 TOOL: ADULT LIPID GUIDELINES (CONTINUED) SUTTER HEALTH CAMPAIGNTOOLKIT
11 SUTTER HEALTH ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE TOOL: ADULT LIPID GUIDELINES (CONTINUED) 83
12 TOOL: ADULT LIPID GUIDELINES (CONTINUED) SUTTER HEALTH CAMPAIGNTOOLKIT
Goals for Today s Session Upon completion of this activity, participants should be able to return to their practices with ideas to improve adherence
Improving Care Delivery: Assessing and Addressing the Risk of Cardiovascular Disease for Patients with Diabetes Robert A Crossey, DO Francis R Colangelo, MD Holly Kern, RN March 25, 2017 2 Goals for Today
Blue Shield Participation
9 th Annual Right Care Initiative Summit Blue Shield Participation Scott Flinn, MD Regional Medical Director Blue Shield of California 1 Care Worthy of our Family and Friends 2 Bottom Line Up Front Blue
Getting to the Heart of the Matter: Hypertension and The Million Hearts Initiative
Click to edit Master title style Getting to the Heart of the Matter: Hypertension and The Million Hearts Initiative Laura Rappleye, Bruce Maki & Teri Wilson (MDCH) M-CEITA / Altarum Institute April 16,
Improving Type 2 Diabetes Therapy Compliance and Persistence in the Kingdom of Saudi Arabia
July 2016 Improving Type 2 Diabetes Therapy Compliance and Persistence in the Kingdom of Saudi Arabia Appendix PATIENT ACTIVATION Introduction This Appendix document provides supporting material for the
Best Practices in Cardiac Care: Getting with the Guidelines
Best Practices in Cardiac Care: Getting with the Guidelines December 9, 2014 Agenda Cardiovascular Disease: How do the guidelines fit into an implementation scheme? What the guidelines set out to accomplish
Supplementary Online Content
Supplementary Online Content Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in cardiology practices
Measure Up Pressure Down. Scott Flinn MD Fritz Steen RN
Measure Up Pressure Down Scott Flinn MD Fritz Steen RN Arch Health Partners AHP is a 1206 (l) Medical Foundation and 501(c)3 Community Benefit organization formed by Palomar Pomerado Health and Centre
Lipid Management 2013 Statin Benefit Groups
Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date
Dyslipidemia and Combination Therapy: A Framework for Clinical Decision Making
Dyslipidemia and Combination Therapy: A Framework for Clinical Decision Making Shashank Sinha, MD Pamela B. Morris, MD, FACC 8 October 2016 Mexico City Introduction: Pamela B. Morris, MD, FACC COMING TO
Agenda. Immunization Registry Reporting in Community Health Centers. Presented by: Ben Pierson Program Manager Health Information Exchange
Immunization Registry Reporting in Community Health Centers Presented by: Ben Pierson Program Manager Health Information Exchange Agenda Introduction About OCHIN Vaccination support in EHR Immunization
Diabetes Care begins with Diabetes Prevention. Neha Sachdev, MD Janet Williams, MA
Diabetes Care begins with Diabetes Prevention Neha Sachdev, MD Janet Williams, MA Objectives Describe the clinical practice burden and trends in type 2 diabetes Review evidence for diabetes prevention
August 2015 Campaign Updates
August 2015 Campaign Updates Q2 2015 Deadline: September 4, 2015 To report your data, please submit via our portal by September 4: https://members.measureup pressuredown.com/ Questions? Email: mupddataadmin@amga.org
Engaging patients and providers with the right information, at the right time, to do the right thing
Engaging patients and providers with the right information, at the right time, to do the right thing Using Automated Patient Engagement and Clinical Decision Support tools to Improve Outcomes and Reduce
Improving Type 2 Diabetes Therapy Adherence and Persistence in Mexico
July 2016 Improving Type 2 Diabetes Therapy Adherence and Persistence in Mexico Appendix PATIENT ACTIVATION Introduction This Appendix document provides supporting material for the report entitled Improving
2014 Update in Medicine Update in Cholesterol Management. Donald L. Lappé MD, FACC, FAHA October 31, 2014
2014 Update in Medicine Update in Cholesterol Management Donald L. Lappé MD, FACC, FAHA October 31, 2014 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular
Preventing 1 Million Heart Attacks and Strokes by 2022
Preventing 1 Million Heart Attacks and Strokes by 2022 Miriam Patanian, MPH Senior Consultant for Health Systems and Cardiovascular Health National Association of Chronic Disease Directors Million Hearts
Improving Type 2 Diabetes Therapy Compliance and Persistence in Brazil
July 2016 Improving Type 2 Diabetes Therapy Compliance and Persistence in Brazil Appendix PATIENT ACTIVATION Introduction This Appendix document provides supporting material for the report entitled Improving
Medical Apps for Cardiology Uses. There s an App for That!
Medical Apps for Cardiology Uses There s an App for That! Audience Participation Question #1 1. ASCVD Risk App What is the predicted 10 year CV event rate for a 57 y/o black male patient with treated
Drug Coverage for EpiPens to Change July 1
Drug Coverage for EpiPens to Change July 1 Epinephrine auto-injector pens (e.g., EpiPen and Adrenaclick ) have seen recent cost increases, now with a price tag of more than $600 for each prescription.
A Case Study on Visual Analytics for Optimizing Drug Duplicate Alerts in a Medication Clinical Decision Support System
A Case Study on Visual Analytics for Optimizing Drug Duplicate Alerts in a Medication Clinical Decision Support System Jaehoon Lee, PhD Wendi L. Record, PharmD Nathan C. Hulse, PhD Intermountain Healthcare
When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes
When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes Kim K. Birtcher, MS, PharmD, AACC, FNLA, CLS, BCPS (AQ-Cardiology), CDE Clinical Professor University of Houston College
Measuring Hypertension Control. Reporting Methods for Measure Up/Pressure Down
Measuring Hypertension Control and Reporting Methods for Measure Up/Pressure Down November 2013 Agenda Recent guideline activity regarding cardiovascular disease Current measurement approach for Measure
4/24/15. AHA/ACC 2013 Guideline Key Points
Review of the ACC/AHA 2013 Guidelines Anita Ralstin, MS, CNS, CNP Next Step Health Consultant, LLC 1! Discuss the rationale for the change in lipid guidelines and how that affects the decision to implement
Cholesterol Management Roy Gandolfi, MD
Cholesterol Management 2017 Roy Gandolfi, MD Goals Interpreting cholesterol guidelines Cholesterol treatment in diabetics Statin use and side effects therapy Reporting- Comparison data among physicians
CMMI Project: San Diego A Heart Attack and Stroke Free Zone. Parag Agnihotri, MD Chair of the Healthcare Committee
CMMI Project: San Diego A Heart Attack and Stroke Free Zone Parag Agnihotri, MD Chair of the Healthcare Committee San Diego: A Heart Attack and Stroke Free Zone Goal Reduce heart attacks and strokes by
Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)
Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) 2. Welcome by Stacey Sheridan, MD, MPH Hello. My name is Stacey Sheridan, and I m here as your partner in Heart Health Now. The North
2/10/2016. Perspectives on the 2013 ACC/AHA Cholesterol Guidelines. Disclosures. ATP-III Update 2004
Perspectives on the 2013 ACC/AHA Cholesterol Guidelines Donald M. Lloyd-Jones, MD ScM Senior Associate Dean Chair and Professor of Preventive Medicine Northwestern Feinberg School of Medicine Disclosures
MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL
MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL JENNIFER BUSSELL MD FACP INSTITUTE FOR HEALTHCARE IMPROVEMENT 15 TH ANNUAL INTERNATIONAL SUMMIT ON IMPROVING PATIENT CARE IN THE OFFICE PRACTICE AND
Aha blood pressure guidelines 2016 chart. Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu
Search for: Search Search Aha blood pressure guidelines 2016 chart Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu 10-2-2012 Here we explain what blood pressure is, how it is measured, and
Long-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA
Long-Term Management Of the ACS Patient: State-of-the-Art Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA Disclosures I have no disclosures. Case Study 45 y/o male admitted to
Team-Based Decision Support in Diabetes Outcomes and Costs
Team-Based Decision Support in Diabetes Outcomes and Costs Session 89, 8:30 a.m. February 13, 2019 Gary Ozanich, Ph.D. - College of Informatics, Northern Kentucky University 1 Conflict of Interest Gary
Deep Dive into Contemporary Cholesterol Management. Kim Allan Williams, Sr., MD, FACC Pamela B. Morris, MD, FACC 7 October 2016 Mexico City
Deep Dive into Contemporary Cholesterol Management Kim Allan Williams, Sr., MD, FACC Pamela B. Morris, MD, FACC 7 October 2016 Mexico City Introduction: Pamela B. Morris, MD, FACC COMING TO CONSENSUS IN
2014/10/20. Management of Lipid Disorders Eric Klug Sunninghill, Sunward Park and CM JHB Academic Hospitals
Management of Lipid Disorders Eric Klug Sunninghill, Sunward Park and CM JHB Academic Hospitals Sudden and unexpected deaths in an adult population, Cape Town, South Africa, 2001-2005 1 Sudden and unexpected
2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Program Evaluation Program Title: Diabetes Program Evaluation Period: January 1, 2017 December
Steps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life Your Guide to Ischemic What Happened to Me? You had a stroke. The stroke you had
ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS
ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Adjunct
Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner
2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current
Achieving Cholesterol Management Goals: Identifying Clinician-Centered Challenges to Optimal Patient Care
Achieving Cholesterol Management Goals: Identifying Clinician-Centered Challenges to Optimal Patient Care Purpose Explore the adherence rates to cholesterol treatment targets among patients who seek care
New Models of Evidence Generation and Cancer Care Delivery: Distance Medicine Technologies
New Models of Evidence Generation and Cancer Care Delivery: Distance Medicine Technologies Susan K. Peterson, PhD, MPH National Cancer Policy Summit Institute of Medicine November 4, 2013 How distance
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth
Improving Type 2 Diabetes Therapy Adherence and Persistence in the United States
July 2016 Improving Type 2 Diabetes Therapy Adherence and Persistence in the United States Appendix PATIENT ACTIVATION Introduction This Appendix document provides supporting material for the report entitled
Preventing and Addressing Chronic Disease. Tim Nikolai, Sr. Community Health Director
Preventing and Addressing Chronic Disease Tim Nikolai, Sr. Community Health Director Disclosures I have no actual or potential conflict of interests involving the materials in this presentation. & Target:
Driving Outcomes By Scaling Population Health Management
Driving Outcomes By Scaling Population Health Management Henry C. Chueh, MD, MS, FACMI March 3, 2016 Laboratory of Computer Science Massachusetts General Hospital Conflict of Interest Henry C. Chueh: Consultant
2014 Evidence-Based HTN Guideline: Preliminary Data from AMGA s Anceta Collaborative
2014 Evidence-Based HTN Guideline: Preliminary Data from AMGA s Anceta Collaborative February 2014 Patient Population Measure spec for MU/PD generally follows NQF 0018 (used for HEDIS, PQRS, and MU) 1.6
MedStar St. Mary s Hospital Pioneers In Quality Presentation. Presenter: Elizabeth Ballard, MSN, RN and Dawn Yeitrakis MS, RN, CEN
MedStar St. Mary s Hospital Pioneers In Quality Presentation Presenter: Elizabeth Ballard, MSN, RN and Dawn Yeitrakis MS, RN, CEN 1 MedStar St. Mary's Hospital (MSMH) Mission & Vision Our Mission MedStar
Treating Hypertension in 2018: What Makes the Most Sense Today?
Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or
PDMP Tools to Identify Red Flag Situations
PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management
Tobacco screening and follow-up if positive for tobacco use
1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 5 45 4 35 3 25 2 15 1 5 16 14 12 1 8 6 4 2 1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 1
Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
American Diabetes Association 2018 Guidelines Important Notable Points
American Diabetes Association 2018 Guidelines Important Notable Points The Standards of Medical Care in Diabetes-2018 by ADA include the most current evidencebased recommendations for diagnosing and treating
Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND
Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND Discuss the core principles of quality management for diabetes care and education Identify the 6 core elements of the Chronic
Observations on US CVD Prevention Guidelines. Donald M. Lloyd-Jones, MD ScM FACC FAHA
Observations on US CVD Prevention Guidelines Donald M. Lloyd-Jones, MD ScM FACC FAHA What are Guidelines? Evidence Base for Guidelines Tricoci, JAMA 2009 Evidence Base for Guidelines Tricoci, JAMA 2009
Leverage Healthcare Technology Applications to Improve Primary Nonadherence.
Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
Target: BP Overview with Lake Superior QIN Wednesday, February 22, :00 PM 1:00 PM CST
Target: BP Overview with Lake Superior QIN Wednesday, February 22, 2017 12:00 PM 1:00 PM CST Presenters American Heart Association Stefanie Worth, Senior Community Health Director, Michigan Sueling Schardin,
Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star
Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating
Crossing The Quality Chasm: Cardiovascular Care
Crossing The Quality Chasm: Cardiovascular Care Philip Madvig, MD Associate Executive Director Partnership for Quality Care Chronic Disease Summit March 19, 2008 The Impact of Cardiovascular Disease In
Measure Up/Pressure Down Medical Group Success
Measure Up/Pressure Down Medical Group Success Deborah A. Molina, MPA, MBA Manager, Quality Jamie L. Reedy, MD, MPH Medical Director, Population Health Laura Balsamini, Pharm D, BCPS Director, Pharmacy
NQF Members NQF Staff Voting Draft Report: NQF-Endorsed Measures for Cardiovascular DA: October 17, 2016
Memo TO: FR: RE: NQF Members NQF Staff Voting Draft Report: NQF-Endorsed Measures for Cardiovascular DA: October 17, 2016 Background Phase 4 of this project, the 24-member Cardiovascular Standing Committee
2013 Cholesterol Guidelines. Anna Broz MSN, RN, CNP, AACC Adult Certified Nurse Practitioner North Ohio Heart, Inc.
2013 Cholesterol Guidelines Anna Broz MSN, RN, CNP, AACC Adult Certified Nurse Practitioner North Ohio Heart, Inc. Disclosures Speaker Gilead Sciences NHLBI Charge to the Expert Panel Evaluate higher quality
Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC
Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC IHI 15 th Annual International Summit on Improving Patient Care in the Office Practice and the Community Peter Basch, MD,
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
Physicians and QIOs Improving Health Outcomes Together. AHQA 2014 Annual Meeting
Physicians and QIOs Improving Health Outcomes Together AHQA 2014 Annual Meeting Aims for Today Introduce AMA focus on improving health outcomes Describe our work on: Preventing cardiovascular disease and
Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-statin Therapies for LDL-C Lowering in the Management of ASCVD Risk Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
Steps Against Recurrent Stroke (STARS)
Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic Stroke What happened to me? You had a stroke. The stroke
Disclosure. I have no relevant financial relationships with commercial interests to disclose American Medical Association. All rights reserved.
Disclosure I have no relevant financial relationships with commercial interests to disclose. 2 Objectives Describe the trends in type 2 diabetes and implications for clinical practice Review the evidence
Preventive Cardiology Scientific evidence
Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention
Health Care Systems Research Network (HCSRN) Conference April 12, 2018 Minneapolis, MN
Health Care Systems Research Network (HCSRN) Conference April 12, 2018 Minneapolis, MN Impact of the Latest USPSTF Recommendations for Statin Use for Primary Cardiovascular Prevention on Payers and Care
Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies
Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Megan Willson, PharmD, BCPS; Catrina Schwartz, PharmD, BS; Jennifer Robinson, PharmD Spokane,
A COMPREHENSIVE APPROACH TO MANAGING DIABETES
A COMPREHENSIVE APPROACH TO MANAGING DIABETES Programs and services to help individuals avoid costly complications and improve outcomes 2 0 1 8 ENTER Supporting each member with targeted guidance and services.
High-quality diabetes care can
Development and Evolution of a Primary Care Based Diabetes Disease Management Program Robb Malone, PharmD, CDE, CPP; Betsy Bryant Shilliday, PharmD, CDE, CPP; Timothy J. Ives, PharmD, MPH; and Michael
Diagnosis and Management of Type 2 Diabetes Mellitus in Adults
Quality Improvement Support: Diagnosis and Management of Type 2 Diabetes Mellitus in Adults The Aims and Measures section is intended to provide guideline users with a menu of measures for multiple purposes,
ACC/AHA Guidelines Bulls-eyes and Misses
ACC/AHA Guidelines Bulls-eyes and Misses James Trippi, MD, FACC Diplomate American Board of Clinical Lipidology Complex Cholesterol Center of St. Vincent Health Indianapolis, IN October 18, 2014 Level
Cardio-Protective Medication Bundle. Louis H. Carter II, PharmD.
Cardio-Protective Medication Bundle Louis H. Carter II, PharmD. 1 Objectives 1. Discuss cardio-protective medication bundle and the reason it is needed 2. Review medications consisted within the bundle
Case Studies The Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk
Case Studies The Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk Kim K. Birtcher, PharmD, MS, AACC Clinical Professor University of Houston College of Pharmacy Houston,
Primary Prevention of Cardiovascular Disease (CVD) Events with Statins. 1 Primary Prevention of Cardiovascular Disease (CVD) Events with Statins
Primary Prevention of Cardiovascular Disease (CVD) Events with Statins 1 Primary Prevention of Cardiovascular Disease (CVD) Events with Statins 2 Welcome by Michael Pignone, MD, MPH Hi, my name is Dr.
CARD 1: What is AFib and how does it relate to stroke? Talk to your patient about their condition and its connection to stroke.
4WARD CONVERSATION CARDS OVERVIEW Please find educational materials to facilitate shared decision making between you and your atrial fibrillation (AFib) patients. More information can be found at AFib4WARD.com.
2013 Cholesterol Guidelines. Anna Broz MSN, RN, CNP, AACC Cer=fied Adult Nurse Prac==oner North Ohio Heart, Inc.
2013 Cholesterol Guidelines Anna Broz MSN, RN, CNP, AACC Cer=fied Adult Nurse Prac==oner North Ohio Heart, Inc. Disclosures Speaker Gilead Sciences NHLBI Charge to the Expert Panel Evaluate higher quality
NEW GUIDELINES FOR CHOLESTEROL
NEW GUIDELINES FOR CHOLESTEROL NEW CHOLESTEROL GUIDELINES 2013 Recently updated guidelines for the treatment of high blood cholesterol levels is a major update since 2002. The news media have trumpeted
Patient Education. intermountainhealthcare.org/diabetes. BG Tracker. for people with diabetes MONITORING BLOOD GLUCOSE
Patient Education intermountainhealthcare.org/diabetes Tracker for people with diabetes MONITORING BLOOD GLUCOSE Title Case My name/phone: Contact numbers: Healthcare provider: Diabetes educator: Pharmacy:
2015 Healthy Heart. Program Evaluation. Our mission is to improve the health and quality of life of our members
2015 Healthy Heart Program Evaluation Our mission is to improve the health and quality of life of our members 2015 Healthy Heart Program Evaluation Program Title: Healthy Heart Program Evaluation Period:
CONVERSATION STARTERS: ENGAGING YOUR PATIENTS AT PICK UP JULY 12, :00 2:30 PM
CONVERSATION STARTERS: ENGAGING YOUR PATIENTS AT PICK UP JULY 12, 2017 1:00 2:30 PM ACPE UAN: 0107-9999-17-097-L04-P 0.15 CEU/1.5 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists:
9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.
UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,
Effective Strategies to Help Customers Use Their EHR to Improve Quality of Care
Effective Strategies to Help Customers Use Their EHR to Improve Quality of Care Brian Bamberger Life Sciences Practice Leader Technology is transforming healthcare Health technology will continue to diffuse
Purpose: To establish a guideline in order to reduce ASCVD risk based the four identified statin benefit groups
Title: Algorithm Based on AHA-13 Report on Lipids Date Created: 11/30/2015 Date Modified: N/A Date Approved by Board of Directors: 12/08/2015 Clinical Guideline # CGC-CG-12 Purpose: To establish a guideline
BACKGROUND: Formal networks of practices are well-established platforms for learning and sharing pragmatic lessons about clinical practice to improve
BACKGROUND: Formal networks of practices are well-established platforms for learning and sharing pragmatic lessons about clinical practice to improve patient care. Among network practices, clinical quality
HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016
HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016 NOTHING TO DISCLOSE I, Nicole Slater, have no actual or potential conflict
= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE
Managing Diabetes for Improved Cardiovascular Health Jimmi Norris MS, RN, CDE An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906 0123. Step 2: Enter code 2071585#. Step 3:
CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW
CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet
Guidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials
PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial
Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk
1/5 MENU ORIGINAL RESEARCH 3 JULY 2018 Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk Article, Author, and Disclosure Information PREV
The MetroHealth System. Creating the HIT Organizational Culture at MetroHealth. Creating the HIT Organizational Culture
CASE STUDY CASE STUDY The MetroHealth System Optimizing Health Information Technology to Increase Vaccination Rates The MetroHealth System in Cleveland, Ohio, was the first safety-net health care system
MU - Selection & Configuration of Measures
MU - Selection & Configuration of Measures Presenter: Christy Erickson October 14, 2011 Objectives Review the 15 Core Measures and highlight some findings from the field Discuss the MU Menu and Clinical
Managing Dyslipidemia and ASCVD Risk: Confusion, Controversy Consensus
Managing Dyslipidemia and ASCVD Risk: Confusion, Controversy Consensus Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA Chair, ACC Prevention of Cardiovascular Disease Council and Section The Medical University
Managing Chronic Kidney Disease: Reducing Risk for CKD Progression
Managing Chronic Kidney Disease: Reducing Risk for CKD Progression Arasu Gopinath, MD Clinical Nephrologist, Medical Director, Jordan Landing Dialysis Center Objectives: Identify the most important risks
9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance
Pharmacy Quality Measures: Action Steps for Improvement Financial Support Financial support was provided for this activity through an unrestricted grant from Health Mart Systems, Inc. Christine Jacobson
CMS-3311-P 100 TABLE 6: MEANINGFUL USES OBJECTIVES AND MEASURES FOR 2015 THROUGH 2017
CMS-3311-P 100 TABLE 6: MEANINGFUL USES OBJECTIVES AND MEASURES FOR 2015 THROUGH 2017 Provider Type Eligible Professional Proposed Objectives for 2015, 2016 and 2017 CPOE Prescribing Clinical Decision
Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017
Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT